13 INVITED KidsCancerKinome: a EU-FP6 project for preclinical kinase inhibitor evaluation as a tool to prioritize compounds for paediatric development.

MLA

Caron, H., et al. “13 INVITED KidsCancerKinome: A EU-FP6 Project for Preclinical Kinase Inhibitor Evaluation as a Tool to Prioritize Compounds for Paediatric Development.” EJC Supplements, vol. 6, no. 12, Oct. 2008, pp. 8–9. EBSCOhost, https://doi.org/10.1016/S1359-6349(08)71945-1.

APA

Caron, H., Clifford, S. C., Pietsch, T., Lanvers, C., Shipley, J., denBoer, M. L., Delattre, O., Serra, M., Koch, T., & Vassal, G. (2008). 13 INVITED KidsCancerKinome: a EU-FP6 project for preclinical kinase inhibitor evaluation as a tool to prioritize compounds for paediatric development. EJC Supplements, 6(12), 8–9. https://doi.org/10.1016/S1359-6349(08)71945-1

Chicago

Caron, H., S.C. Clifford, T. Pietsch, C. Lanvers, J. Shipley, M.L. denBoer, O. Delattre, M. Serra, T. Koch, and G. Vassal. 2008. “13 INVITED KidsCancerKinome: A EU-FP6 Project for Preclinical Kinase Inhibitor Evaluation as a Tool to Prioritize Compounds for Paediatric Development.” EJC Supplements 6 (12): 8–9. doi:10.1016/S1359-6349(08)71945-1.